Low molecular weight heparin (LMWH) for primary thrombo-prophylaxis in patients with solid malignancies - systematic review and meta-analysis. [electronic resource]
Producer: 20150330Description: 1230-7 p. digitalISSN:- 1651-226X
- Ambulatory Care
- Cause of Death
- Fibrinolytic Agents -- therapeutic use
- Hemorrhage -- chemically induced
- Heparin, Low-Molecular-Weight -- therapeutic use
- Humans
- Lung Neoplasms -- drug therapy
- Neoplasms -- drug therapy
- Pancreatic Neoplasms -- etiology
- Primary Prevention
- Pulmonary Embolism -- etiology
- Randomized Controlled Trials as Topic
- Venous Thromboembolism -- etiology
- Venous Thrombosis -- etiology
No physical items for this record
Publication Type: Journal Article; Meta-Analysis; Review; Systematic Review
There are no comments on this title.
Log in to your account to post a comment.